Evidence map›Paper›PMID 38417449›Full record

ArticleCancer science2024

Salivary metabolomic biomarkers for non-invasive lung cancer detection.

Naohiro Kajiwara, Masatoshi Kakihana, Junichi Maeda, Miku Kaneko, Sana Ota, Ayame Enomoto, Norihiko Ikeda, Masahiro Sugimoto

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Identifying Biomarkers for Chronic Obstructive Pulmonary Disease in the Salivary Metabolome.International journal of chronic obstructive pulmonary disease · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Naohiro KajiwaraDepartment of Thoracic Surgery, Hachioji Medical Center of Tokyo Medical College Hospital, Hachioji, Tokyo, Japan.
Masatoshi KakihanaDepartment of Surgery, Tokyo Medical University, Tokyo, Japan.
Junichi MaedaDepartment of Surgery, Tokyo Medical University, Tokyo, Japan.
Miku KanekoInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
Sana OtaInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
Ayame EnomotoInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
Norihiko IkedaDepartment of Surgery, Tokyo Medical University, Tokyo, Japan.
Masahiro SugimotoInstitute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.ORCID https://orcid.org/0000-0003-3316-2543
Tokyo Medical University · JPKeio University · JP

Funding

Japan Society for the Promotion of Science JP20H05743Japan Society for the Promotion of Science JP20K09171Japan Society for the Promotion of Science JP22H00595
6 · The paper itself

Abstract

Identifying novel biomarkers for early detection of lung cancer is crucial. Non-invasively available saliva is an ideal biofluid for biomarker exploration; however, the rationale underlying biomarker detection from organs distal to the oral cavity in saliva requires clarification. Therefore, we analyzed metabolomic profiles of cancer tissues compared with those of adjacent non-cancerous tissues, as well as plasma and saliva samples collected from patients with lung cancer (n = 109 pairs). Additionally, we analyzed plasma and saliva samples collected from control participants (n = 83 and 71, respectively). Capillary electrophoresis-mass spectrometry and liquid chromatography-mass spectrometry were performed to comprehensively quantify hydrophilic metabolites. Paired tissues were compared, revealing 53 significantly different metabolites. Plasma and saliva showed 44 and 40 significantly different metabolites, respectively, between patients and controls. Of these, 12 metabolites exhibited significant differences in all three comparisons and primarily belonged to the polyamine and amino acid pathways; N

Indexed as

Biomarkers, TumorLung NeoplasmsMetabolomicsSalivaAdultAgedCase-Control StudiesChromatography, LiquidEarly Detection of CancerElectrophoresis, CapillaryFemaleHumansMaleMass SpectrometryMetabolomeMiddle AgedBiomarkers, Tumorbiomarkerlung cancermetabolomicsplasmasaliva

Identifiers

PMID38417449
PMCPMC11093188
OpenAlexW4392229242

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.